My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 4 results for

GO
Search Filters: Maine cancel Oklahoma cancel Social and Behavioral Health cancel

ASTHO’s 2024 Legislative Session Update: Part One

Data Modernization,
Arizona,
Health Policy Update,
State Health Policy,
Health Equity,
Environmental Health,
New Hampshire,
Oklahoma,
Maine,
Florida,
Colorado,
Tennessee,
Virginia,
Wisconsin,
California,
New Jersey,
Missouri,
Maryland,
New York,
Georgia,
Delaware,
New Mexico,
Hawaii,
Overdose Prevention,
STIs,
Infant and Child Health,
Lillian Colasurdo,
Maggie Davis,
Lana McKinney,
JoAnne McClure

ASTHO’s 2024 Legislative Session Update: Part One legislative session, state policy, data collection, domestic violence, health information exchange, data privacy, substance misuse, overdose ...

Improving Youth Behavioral Health Through School-Based Strategies

Report,
Mental Health,
Suicide Prevention,
ACEs,
Early Brain Development,
Partnership,
COVID and Special Populations,
At-Risk Populations,
Education,
COVID and Mental Health,
COVID and Telehealth,
Telehealth,
Maine,
Maryland,
Michigan,
Oklahoma,
South Carolina,
Tennessee,
Washington,
Youth Mental Health,
Infant and Child Health

The findings detailed in this report were gathered during a series of School Behavioral Health Advisory Committee convenings in spring 2021. The goal was identify policy gaps and strategies for ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

State Health Policy,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, ...